Journal List > J Clin Neurol > v.14(2) > 1095351

TOOLS
Song, Chang, Chun, Lee, Kim, Kim, and Kim: High Dietary Glycemic Load is Associated with Poor Functional Outcome in Patients with Acute Cerebral Infarction
Original Article

Journal of Clinical Neurology (Seoul, Korea) 2018; 14(2): 165-173.

Published online: 10 January 2018

DOI: https://doi.org/10.3988/jcn.2018.14.2.165

High Dietary Glycemic Load is Associated with Poor Functional Outcome in Patients with Acute Cerebral Infarction

Tae-Jin Songa, *, Yoonkyung Changa, *, Min-Young Chuna, Chan-Young Leea, A-Ram Kimb, Yuri Kimb, c, Yong-Jae Kima

aStroke Center, Department of Neurology, Ewha Womans University School of Medicine, Seoul, Korea.

bDepartment of Clinical Nutrition, The Graduate School of Converging Clinical & Public Health, Seoul, Korea.

cDepartment of Nutritional Science and Food Management, Ewha Womans University, Seoul, Korea.

Correspondence: Yong-Jae Kim, MD, PhD. Stroke Center, Department of Neurology, Ewha Womans University School of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 07985, Korea. Tel +82-2-2650-5649, Fax +82-2-2650-5958, brain930@ewha.ac.kr

Equal contributor:

*These authors contributed equally to this work.

Received 23 June 2017       Revised 25 October 2017       Accepted 27 October 2017

Copyright © 2018 Korean Neurological Association

Korean Neurological Association

(open-access, http://creativecommons.org/licenses/by-nc/4.0/):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background and Purpose

Elevated postprandial blood glucose is a critical risk factor for stroke. The dietary glycemic load (GL) and glycemic index (GI) are frequently used as markers of the postprandial blood glucose response to estimate the overall glycemic effect of diets. We hypothesized that high dietary GL, GI, or total carbohydrate intake is associated with a poor functional outcome in patients with acute ischemic stroke.

Methods

We prospectively included 263 first-ever ischemic stroke patients who completed a semiquantitative food-frequency questionnaire. The dietary GL, GI, and total carbohydrate intake were investigated by examining the average frequency of intake during the previous year based on reference amounts for various food items. Poor functional outcome was defined as a score on the modified Rankin Scale (mRS) of ≥3 at 3 months after stroke.

Results

The patients were aged 65.4±11.7 years (mean±standard deviation), and 58.2% of them were male. A multivariate analysis adjusted for age, sex, marital status, prestroke mRS score, diabetes mellitus, hyperlipidemia, body mass index, triglycerides, low-density lipoprotein, hemoglobin A1c, stroke classification, and National Institutes of Health Stroke Scale score, early neurological deterioration, and high-grade white-matter hyperintensities revealed that the dietary GL and total carbohydrate intake were associated with a poor functional outcome, with odds ratios for the top quartile relative to the bottom quartile of 28.93 (95% confidence interval=2.82–296.04) and 36.84 (95% confidence interval=2.99–453.42), respectively (p for trend=0.002 and 0.002, respectively). In contrast, high dietary GI was not associated with a poor functional outcome (p for trend=0.481).

Conclusions

Increased dietary GL and carbohydrate intake were associated with a poor short-term functional outcome after an acute ischemic stroke.

Keywords: glycemic load, glycemic index, carbohydrate intake, stroke, outcome

INTRODUCTION

Elevated postprandial blood glucose is a critical risk factor for stroke regardless of the presence of diabetes mellitus,12 and increased postprandial blood glucose is mostly impacted by the dietary carbohydrate intake.3 Because carbohydrates vary in size, fiber content, and chemical structure, the increase in postprandial blood glucose may vary depending on type of carbohydrate ingested.4 The dietary glycemic load (GL) and glycemic index (GI) are frequently used as markers of the postprandial blood glucose response to estimate the overall impact of dietary carbohydrate intake.5
Previous epidemiological cohort studies have revealed that high GL and GI are associated with the risk of stroke.678 An increased GI predicted a greater risk of mortality after stroke in population-based studies in Japan8 and Australia.9 Because stroke can cause serious handicaps and the short-term function after a first ischemic stroke is associated with the long-term outcome,10 risk factors for poor functional outcome should be evaluated after a stroke. The association of the dietary GL or GI with functional outcome at 3 months after ischemic stroke has not been reported.
A high carbohydrate intake related to a high dietary GL or GI has an unfavorable impact on glucose and lipid metabolism,11 and the impact could potentially increase the risk of vascular events and poor stroke prognosis.1213 We therefore hypothesized that high dietary GL, GI, or total carbohydrate intake is associated with a poor functional outcome in patients with acute ischemic stroke. In this study, we investigated the relationship between the dietary GL or GI and the functional outcome after an acute ischemic stroke.

METHODS

Subjects

We prospectively included 263 patients who were admitted to Ewha Womans University Mokdong Hospital within 7 days after they experienced their first symptomatic ischemic stroke. Patients were evaluated for past medical history, family history, and using brain imaging studies (CT or MRI), vascular imaging studies (digital subtraction angiography, CT angiography, or MR angiography), chest X-ray, 12-lead electrocardiography, transthoracic echocardiography, routine blood tests, and with electrocardiography monitoring for a median period of 3 days at a stroke intensive care unit. Blood samples were collected within 24 hours of admission and after fasting for more than 12 hours, and the following parameters were analyzed: white blood cell count, hemoglobin, fasting glucose, triglycerides, low-density lipoprotein, hemoglobin A1c (HbA1c), insulin, and C-reactive protein.
Strokes were classified according to the Trial of Org 10172 in Acute Stroke Treatment system.14 The severity of neurological deficits was determined by using the National Institutes of Health Stroke Scale (NIHSS) at admission.1516 Early neurological deterioration was defined as any increase in the NIHSS score within 7 days after admission.17 The extent of white-matter hyperintensities (WMHs) was determined on fluid-attenuated inversion recovery images of periventricular white matter or deep white matter according to the Fazekas scoring system. A Fazekas score of ≥2 for the periventricular white matter and/or of ≥2 for the deep white matter was considered indicative of high-grade WMHs.18 The presence of symptomatic cerebral atherosclerosis was defined as >50% stenosis and/or occlusion of extracranial and/or intracranial arteries that could explain stroke-related symptoms based on the North American Symptomatic Carotid Endarterectomy Trial19 or Warfarin-Aspirin Symptomatic Intracranial Disease study,20 respectively. To assess functional outcome, the modified Rankin Scale (mRS) was used. Prestroke mRS score and mRS score at 3 months after the index stroke was assessed by a stroke neurologist and/or a well-trained stroke specialist nurse. This study was conducted with the approval of the Institutional Review Board of Ewha Womans University Mokdong Hospital (approval no. ECT 11-59-21). Informed consent was received from patients and their caregivers.

Semiquantitative food-frequency questionnaire, dietary glycemic load, and glycemic index

The survey was conducted through one-on-one interviews with patients and their caregivers, each of which typically took 20–30 minutes. Dietary intake was assessed with a validated Korean version of a semiquantitative food-frequency questionnaire (SQFFQ).21 The SQFFQ comprised a list of 111 foods, with the average frequency of intake of each food during the previous year reported based on a reference amount. The frequency of food intake was categorized into ‘almost never,’ ‘once a month,’ ‘two or three times a month,’ ‘one or two times a week,’ ‘three or four times a week,’ ‘once a day,’ ‘two times a day,’ and ‘three times a day.’ The amount of each food consumed was categorized into ‘less than the reference amount,’ ‘the reference amount,’ and ‘more than the reference amount.’ Food and nutrient intakes were calculated with the aid of the Computer-Aided Nutritional Analysis Program (version 4.0, Korea Nutrition Society, Seoul, Korea).21
The GI is a measure of the postprandial blood glucose response to carbohydrate intake when compared with a reference foodstuff (either glucose or white bread). The GI can be considered an indicator of the quality of dietary carbohydrates that are consumed. The GI values of foods can be obtained from an international table22 or the http://www.glycemicindex.com website. The dietary GI can be calculated as the sum of GI values of each consumed food item, multiplied by the percentage of carbohydrate content and consumption frequency and divided by the total carbohydrate consumption. The GL is calculated by multiplying the GI of a food item with available carbohydrate content but without dividing by the total carbohydrate consumption, which indicates both the quality and quantity of carbohydrate intake.6 The total carbohydrate intake is measured by summing the scores on validated food-frequency questionnaires.

Risk factors

Hypertension was defined as a resting systolic blood pressure of ≥140 mm Hg or diastolic blood pressure of ≥90 mm Hg on repeated measurements, or treatment with antihypertensive medications. Diabetes mellitus was diagnosed if a patient had a fasting blood glucose level of ≥7.0 mmol/L or was being treated with oral hypoglycemic agents or insulin. Hyperlipidemia was diagnosed for low-density lipoprotein ≥4.1 mmol/L or total cholesterol ≥6.2 mmol/L. Subjects with a recent weekly alcohol intake that regularly exceeded 300 g of ethanol were classified as heavy drinkers. Patients were defined as smokers if they were current smokers or had stopped smoking within the previous year. Body mass index was calculated by dividing body weight by height squared (in units of kg/m2). Patients who had exercised more than once weekly for the past 6 months were classified as performing regular exercise.2324 The marital status was categorized into single (including never married, divorced, separated, or bereaved) and married.

Statistical analysis

Statistical analyses were conducted with the Windows SPSS software package (version 18.0, SPSS Inc., Chicago, IL, USA). The independent t-test, Mann-Whitney U test, one-way analysis of variance with Bonferroni post-hoc analysis, and Kruskal-Wallis test for continuous variables and the chi-square test or Fisher's exact test for categorical variables were applied to quartiles of the dietary GL, GI, and total carbohydrate intake. Trends across quartiles were tested by using the median of each quartile as the predictor in linear models for continuous variables and in logistic models for categorical variables. Functional outcome was dichotomized into good (mRS score <3) or poor (mRS score ≥3) in a binary logistic regression analysis, and subdivided into mRS scores of 0, 1, 2, and 3–6 in an ordinal logistic regression analysis. Univariate and multivariate binary and ordinal logistic regression analyses–with a dependent variable of the mRS score at 3 months after the index stroke–were conducted to determine predictive factors for functional outcome. Multivariate analyses were adjusted for age, sex, variables with p<0.1 in the univariate analysis (marital status, prestroke mRS score, hyperlipidemia, body mass index, stroke classification, NIHSS score, early neurological deterioration, and high-grade WMHs), and variables related to GL, GI, or total carbohydrate intake (diabetes mellitus, triglycerides, low-density lipoprotein, and HbA1c).
There was no interaction of dietary GL with diabetes mellitus or HbA1c (p=0.964 and 0.484, respectively). Multicollinearity was present between dietary GL and the total carbohydrate intake (variance inflation factor was higher than 6 when the dependent variable was defined as the functional outcome at 3 months after the index stroke in multivariate linear regression), and so dietary GL, GI, and total carbohydrate intake were analyzed separately in multivariate analyses. A two-tailed p value of <0.05 was considered indicative of statistical significance.

RESULTS

We first included 306 patients who completed an SQFFQ and were confirmed as having experienced an acute ischemic stroke by brain CT, MRI, or both imaging modalities. Because our study used a survey, patients suspected of having cognitive impairment (Mini-Mental State Examination score <24) or aphasia were not enrolled (n=15).25 After excluding patients for whom clinical information or blood laboratory findings were lacking (n=11), whose daily calorie intake was outside of the range of 500–5,000 kcal (n=4), who had rare causes of stroke such as arterial dissection (n=2) or venous thrombosis (n=1), and for whom outcome data at 3 months after the index stroke were not available (n=10), finally 263 patients were included in this study (Fig. 1).
The included patients were aged 65.4±11.7 years (mean±standard deviation), and 153 (58.2%) of them were male. Their dietary GL and GI were 158.7±72.7 and 59.6±4.8, respectively. Stroke classifications of large-artery atherosclerosis, lacune, and cardioembolism were most common. The median NIHSS score at admission was 3, with an interquartile range of 1–6. Demographic data for the study subjects and comparative analyses according to quartiles of the dietary GL are summarized in Table 1. The prevalence of male sex and a history of diabetes mellitus increased with the dietary GL. In addition, the fasting glucose, triglycerides, HbA1c, high-grade WMHs, dietary GI, total energy intake, total carbohydrate intake, and intakes of fat, protein, dietary fiber, and grains increased with the quartiles of the dietary GL.
The results of comparative analyses according to quartiles of the total carbohydrate intake are summarized in Table 2. The prevalence of a history of diabetes mellitus increased with the intake of total carbohydrate. In addition, fasting glucose, triglycerides, HbA1c, dietary GL, total energy intake, and intakes of fat, protein, dietary fiber, and grains increased with the quartiles of total carbohydrate intake.
The results of a comparative analysis between good and poor outcome groups are presented in Supplementary Table 1 (in the online-only Data Supplement). A multivariate binary logistic analysis revealed that a high dietary GL was associated with an increased risk of a poor functional outcome [odds ratio (OR) for top quartile relative to bottom quartile= 28.93, 95% confidence interval (CI)=2.82–296.04, p for linear trend=0.002]. The total carbohydrate intake was associated with an increased risk of a poor functional outcome (OR for top quartile relative to bottom quartile=36.84, 95% CI=2.99–453.42, p for linear trend=0.002). In contrast, a high dietary GI was not associated with a poor functional outcome (OR for top quartile relative to bottom quartile=3.60, 95% CI=0.54–23.76, p for linear trend=0.481) (Table 3 and Supplementary Tables 2, 3, 4, 5 in the online-only Data Supplement). A multivariate ordinal logistic analysis found that a high dietary GL was associated with an increased risk of a poor functional outcome (OR for top quartile relative to bottom quartile=4.71, 95% CI=1.32–16.78, p for linear trend=0.014). The total carbohydrate intake was associated with an increased risk of a poor functional outcome (OR for top quartile relative to bottom quartile=5.00, 95% CI=1.35–18.62, p for linear trend=0.006), while a high dietary GI was not related to a poor functional outcome (Table 4). In subgroup analysis, high dietary GL and total carbohydrate intake were significantly associated with a poor functional outcome regardless of the presence of diabetes mellitus (Table 4).

DISCUSSION

This study found that increased dietary GL and total carbohydrate intake were independently associated with a poor functional outcome at 3 months after an acute ischemic stroke even after adjusting for stroke classification, NIHSS score at admission, and early neurological deterioration, which are factors that strongly influence stroke outcome. These associations were not affected by diabetes mellitus. The correlations of GL, GI, and the carbohydrate intake with stroke risk and prognosis have not been demonstrated. A previous Italian cohort study found that an increased GL and carbohydrate intake (but not GI) were associated with an increased stroke risk.26 In a Dutch population, high GL, GI, and carbohydrate intake were related to an increased risk of cardiovascular disease (including stroke) during a mean follow-up of 11.9 years.27 The Takayama study revealed that a high dietary GI increased the risk of mortality from stroke in Japanese women.8 A meta-analysis revealed that a high dietary GL was associated with an increased risk of coronary heart disease and stroke, and there was a linear dose-response relationship between the GL and the risk of coronary heart disease.28 In contrast, the dietary GI was only weakly associated with the risk of coronary heart disease, and it was not associated with the risk of stroke or stroke-related death.28 A Swedish study found that the GI and GL were not associated with long-term mortality in middle-aged men.7 These discrepancies between our study and previous studies may be due to differences in study populations (general populations in other studies versus acute ischemic stroke patients in the present study), race, sex distribution, or dietary contributions to the GL and GI.7 The present study has provided new insight into the association of the dietary GL and total carbohydrate intake with the functional outcome after acute ischemic stroke.82627
Several mechanisms could explain the relationships of high GL and total carbohydrate intake with a poor functional outcome found in our study. Chronic hyperglycemia induced by a high dietary GL may impact the stroke outcome.29 A previous study found that chronic hyperglycemia was related to a poor functional outcome in patients with acute ischemic stroke.30 This tendency was also found in a large multicenter stroke registry from Japan.31 Hyperglycemia was associated with more-severe cytotoxic injury, cerebral hypoperfusion, cerebral edema, and hemorrhagic transformation, which are strong prognostic factors after an acute ischemic stroke.323334 Chronic hyperglycemia leads to increased lactate production and promotes mitochondrial dysfunction by creating an acidotic intracellular environment,35 which may aggravate the damage to ischemic tissue. Alternatively, a high dietary GL and GI can suddenly increase the blood sugar level, and such variability is associated with endothelial dysfunction in type 1 and type 2 diabetes mellitus.36 Endothelial dysfunction is a risk factor for cardiovascular disease,37 and impaired flow-mediated dilation (≤4.5%) is associated with a poor outcome in acute ischemic stroke patients with endothelial dysfunction.38 Hyperglycemia and insulin resistance induced by a high dietary GL may impact hypercoagulability by increasing the serum levels of fibrinogen and von Willebrand factor.3940 Our results are also supported by increased thrombotic activity possibly predicting the 1-year functional outcome in patients with ischemic stroke.39
We found that an increased dietary GI was not independently related to a poor functional outcome, although a relationship was found in the univariate analysis. The dietary GL more accurately reflects the amount and quality of blood glucose and insulin increase when consuming carbohydrates than does the dietary GI.41 We speculate that our findings were due to the study design or differences in the predictability of the dietary GL and GI. Further investigations are needed to confirm these differences.
This study was subject to some limitations. First, although patients with acute ischemic stroke were enrolled prospectively, patients with cognitive dysfunction or severe neurological deficit were excluded. This means that our study results are not representative of overall ischemic stroke. Second, this study was limited to Korean stroke patients. Because the dietary habits of Korean patients differ from those in other countries, the study results are difficult to generalize beyond Korea. Third, the smallness of the sample and the questionnaire survey design of our study may have caused selection and/or recall bias. Further large-scale and long-term cohort studies are therefore needed.
In conclusion, an increased dietary GL and total carbohydrate intake were associated with a poor functional outcome after an acute ischemic stroke. Low-GL food and a low-carbohydrate diet may improve the prognosis after an acute ischemic stroke.

Acknowledgements

This work was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant no. 2015R1D1A1A01057934).

Notes

Conflicts of Interest: The authors have no financial conflicts of interest.

References

1. Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med. 2004; 164:2147–2155. PMID: 15505129.
2. Zhang Z, Yan J, Shi H. Hyperglycemia as a risk factor of ischemic stroke. J Drug Metab Toxicol. 2013; 4:153. PMID: 25328819.
crossref
3. Levitan EB, Cook NR, Stampfer MJ, Ridker PM, Rexrode KM, Buring JE, et al. Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein. Metabolism. 2008; 57:437–443. PMID: 18249220.
crossref
4. Aston LM. Glycaemic index and metabolic disease risk. Proc Nutr Soc. 2006; 65:125–134. PMID: 16441952.
crossref
5. Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981; 34:362–366. PMID: 6259925.
crossref
6. Oh K, Hu FB, Cho E, Rexrode KM, Stampfer MJ, Manson JE, et al. Carbohydrate intake, glycemic index, glycemic load, and dietary fiber in relation to risk of stroke in women. Am J Epidemiol. 2005; 161:161–169. PMID: 15632266.
crossref
7. Levitan EB, Mittleman MA, Håkansson N, Wolk A. Dietary glycemic index, dietary glycemic load, and cardiovascular disease in middleaged and older Swedish men. Am J Clin Nutr. 2007; 85:1521–1526. PMID: 17556687.
crossref
8. Oba S, Nagata C, Nakamura K, Fujii K, Kawachi T, Takatsuka N, et al. Dietary glycemic index, glycemic load, and intake of carbohydrate and rice in relation to risk of mortality from stroke and its subtypes in Japanese men and women. Metabolism. 2010; 59:1574–1582. PMID: 20303126.
crossref
9. Kaushik S, Wang JJ, Wong TY, Flood V, Barclay A, Brand-Miller J, et al. Glycemic index, retinal vascular caliber, and stroke mortality. Stroke. 2009; 40:206–212. PMID: 18948616.
crossref
10. Magalhães R, Abreu P, Correia M, Whiteley W, Silva MC, Sandercock P. Functional status three months after the first ischemic stroke is associated with long-term outcome: data from a community-based cohort. Cerebrovasc Dis. 2014; 38:46–54. PMID: 25226861.
crossref
11. Aeberli I, Gerber PA, Hochuli M, Kohler S, Haile SR, Gouni-Berthold I, et al. Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am J Clin Nutr. 2011; 94:479–485. PMID: 21677052.
crossref
12. Luitse MJ, van Seeters T, Horsch AD, Kool HA, Velthuis BK, Kappelle LJ, et al. Admission hyperglycaemia and cerebral perfusion deficits in acute ischaemic stroke. Cerebrovasc Dis. 2013; 35:163–167. PMID: 23429063.
crossref
13. Mucci L, Santilli F, Cuccurullo C, Davì G. Cardiovascular risk and dietary sugar intake: is the link so sweet? Intern Emerg Med. 2012; 7:313–322. PMID: 21544534.
crossref
14. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24:35–41. PMID: 7678184.
crossref
15. Song TJ, Kim J, Song D, Nam HS, Kim YD, Lee HS, et al. Association of cerebral microbleeds with mortality in stroke patients having atrial fibrillation. Neurology. 2014; 83:1308–1315. PMID: 25186853.
crossref
16. Oh MS, Yu KH, Lee JH, Jung S, Ko IS, Shin JH, et al. Validity and reliability of a Korean version of the National Institutes of Health Stroke Scale. J Clin Neurol. 2012; 8:177–183. PMID: 23091526.
crossref
17. Kim YD, Song D, Kim EH, Lee KJ, Lee HS, Nam CM, et al. Longterm mortality according to the characteristics of early neurological deterioration in ischemic stroke patients. Yonsei Med J. 2014; 55:669–675. PMID: 24719133.
crossref
18. Song TJ, Kim YD, Yoo J, Kim J, Chang HJ, Hong GR, et al. Association between aortic atheroma and cerebral small vessel disease in patients with ischemic stroke. J Stroke. 2016; 18:312–320. PMID: 27488980.
crossref
19. North American, Barnett HJM, Taylor DW, Haynes RB, Sackett DL, Peerless SJ, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991; 325:445–453. PMID: 1852179.
crossref
20. Warfarin-Aspirin Symptomatic. WASID) Trial Investigators. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology. 2003; 22:106–117. PMID: 12656117.
21. Choe H, Hwang JY, Yun JA, Kim JM, Song TJ, Chang N, et al. Intake of antioxidants and B vitamins is inversely associated with ischemic stroke and cerebral atherosclerosis. Nutr Res Pract. 2016; 10:516–523. PMID: 27698959.
crossref
22. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002; 76:5–56. PMID: 12081815.
crossref
23. Song TJ, Cho HJ, Chang Y, Choi K, Jung AR, Youn M, et al. Low plasma proportion of omega 3-polyunsaturated fatty acids predicts poor outcome in acute non-cardiogenic ischemic stroke patients. J Stroke. 2015; 17:168–176. PMID: 26060804.
crossref
24. Song TJ, Kim J, Lee HS, Nam CM, Nam HS, Kim EH, et al. Differential impact of unrecognised brain infarction on stroke outcome in nonvalvular atrial fibrillation. Thromb Haemost. 2014; 112:1312–1318. PMID: 25231184.
crossref
25. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992; 40:922–935. PMID: 1512391.
crossref
26. Sieri S, Brighenti F, Agnoli C, Grioni S, Masala G, Bendinelli B, et al. Dietary glycemic load and glycemic index and risk of cerebrovascular disease in the EPICOR cohort. PLoS One. 2013; 8:e62625. PMID: 23717392.
crossref
27. Burger KN, Beulens JW, Boer JM, Spijkerman AM, van der A DL. Dietary glycemic load and glycemic index and risk of coronary heart disease and stroke in Dutch men and women: the EPIC-MORGEN study. PLoS One. 2011; 6:e25955. PMID: 21998729.
crossref
28. Fan J, Song Y, Wang Y, Hui R, Zhang W. Dietary glycemic index, glycemic load, and risk of coronary heart disease, stroke, and stroke mortality: a systematic review with meta-analysis. PLoS One. 2012; 7:e52182. PMID: 23284926.
crossref
29. Brand-Miller JC, Holt SH, Pawlak DB, McMillan J. Glycemic index and obesity. Am J Clin Nutr. 2002; 76:281S–285S. PMID: 12081852.
crossref
30. Luitse MJ, Velthuis BK, Kappelle LJ, van der Graaf Y, Biessels GJ. DUST Study Group. Chronic hyperglycemia is related to poor functional outcome after acute ischemic stroke. Int J Stroke. 2017; 12:180–186. PMID: 27784821.
crossref
31. Kamouchi M, Matsuki T, Hata J, Kuwashiro T, Ago T, Sambongi Y, et al. Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry. Stroke. 2011; 42:2788–2794. PMID: 21817134.
32. Bevers MB, Vaishnav NH, Pham L, Battey TW, Kimberly WT. Hyperglycemia is associated with more severe cytotoxic injury after stroke. J Cereb Blood Flow Metab. 2017; 37:2577–2583. PMID: 27671250.
crossref
33. González-Moreno EI, Cámara-Lemarroy CR, González-González JG, Góngora-Rivera F. Glycemic variability and acute ischemic stroke: the missing link? Transl Stroke Res. 2014; 5:638–646. PMID: 25085437.
crossref
34. Quast MJ, Wei J, Huang NC, Brunder DG, Sell SL, Gonzalez JM, et al. Perfusion deficit parallels exacerbation of cerebral ischemia/reperfusion injury in hyperglycemic rats. J Cereb Blood Flow Metab. 1997; 17:553–559. PMID: 9183293.
crossref
35. Anderson RE, Tan WK, Martin HS, Meyer FB. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke. 1999; 30:160–170. PMID: 9880405.
36. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008; 57:1349–1354. PMID: 18299315.
crossref
37. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000; 101:948–954. PMID: 10704159.
crossref
38. Santos-García D, Blanco M, Serena J, Arias S, Millán M, Rodríguez-Yáñez M, et al. Brachial arterial flow mediated dilation in acute ischemic stroke. Eur J Neurol. 2009; 16:684–690. PMID: 19236459.
crossref
39. Raynaud E, Pérez-Martin A, Brun J, Aïssa-Benhaddad A, Fédou C, Mercier J. Relationships between fibrinogen and insulin resistance. Atherosclerosis. 2000; 150:365–370. PMID: 10856528.
crossref
40. Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA. 2000; 283:221–228. PMID: 10634338.
41. Bao J, Atkinson F, Petocz P, Willett WC, Brand-Miller JC. Prediction of postprandial glycemia and insulinemia in lean, young, healthy adults: glycemic load compared with carbohydrate content alone. Am J Clin Nutr. 2011; 93:984–996. PMID: 21325437.
crossref

Supplementary Materials

The online-only Data Supplement is available with this article at https://doi.org/10.3988/jcn.2018.14.2.165.

Supplementary Table 1

Comparison of demographic and clinical data according to functional outcomes dichotomized into poor and good (scores on the mRS of ≥3 and <3, respectively)
jcn-14-165-s001.pdf

Supplementary Table 2

Results of multivariate analysis for poor functional outcome regarding dietary GL.
jcn-14-165-s002.pdf

Supplementary Table 3

Results of multivariate analysis for poor functional outcome regarding total carbohydrate intake
jcn-14-165-s003.pdf

Supplementary Table 4

Results of multivariate analysis for poor functional outcome regarding dietary GL after excluding the prestroke mRS score*
jcn-14-165-s004.pdf

Supplementary Table 5

Results of multivariate analysis for poor functional outcome regarding total carbohydrate intake after excluding the prestroke mRS score*
jcn-14-165-s005.pdf
Fig. 1

Flow chart depicting the participation of subjects in this study.

jcn-14-165-g001
Table 1

Comparison of demographic and clinical data according to quartiles of dietary GL

jcn-14-165-i001
Variables Q1 (n=66) Q2 (n=65) Q3 (n=66) Q4 (n=66) Total (n=263) p* p for trend†
GL 90.2 [77.0–98.0] 125.3 [113.8–135.8] 170.6 [163.2–182.1] 222.2 [201.9–268.8] 144.9 [106.0–188.5]
Demographic data
 Sex, male 32 (48.5) 36 (55.4) 43 (65.2) 42 (63.6) 153 (58.2) 0.042 0.042
 Age, years 65.8±13.3 65.9±12.2 66.1±10.9 63.8±10.4 65.4±11.7 0.654 0.116
 Marital status, married 39 (59.1) 44 (67.7) 45 (68.2) 44 (66.7) 172 (65.4) 0.375 0.375
 Education, >7 years 14 (21.2) 14 (21.5) 10 (15.2) 11 (16.7) 49 (18.6) 0.718 0.352
 Prestroke mRS score 0 [0–1] 0 [0–1] 0 [0–1] 0 [0–1] 0 [0–1] 0.165 0.520
Risk factors
 Hypertension 25 (37.9) 32 (49.2) 32 (48.5) 32 (48.5) 121 (46.0) 0.502 0.257
 Diabetes mellitus 12 (18.2) 22 (33.8) 26 (39.4) 34 (51.5) 94 (35.7) 0.001 0.001
 Hyperlipidemia 11 (16.7) 20 (30.8) 13 (19.7) 10 (15.2) 54 (20.5) 0.113 0.487
 Alcohol intake 24 (36.4) 27 (41.5) 31 (47.0) 36 (54.5) 118 (44.9) 0.734 0.029
 Smoking 23 (34.8) 22 (33.8) 29 (43.9) 29 (43.9) 103 (39.2) 0.466 0.166
 Body mass index, kg/m2 24.2±3.5 27.3±2.4 23.7±2.8 24.0±3.5 24.8±2.2 0.307 0.442
 Regular exercise 22 (33.3) 22 (33.8) 26 (39.4) 25 (37.9) 95 (36.1) 0.858 0.470
Laboratory findings
 White blood cell count, ×103/µL 7.0±3.1 6.9±1.9 7.8±2.6 7.9±3.3 7.4±2.8 0.099 0.208
 Hemoglobin, mg/dL 13.4±1.6 13.2±1.4 13.3±2.0 13.3±1.6 13.3±1.6 0.946 0.953
 Fasting glucose, mg/dL 112.7±36.0 114.6±36.0 124.1±38.8 127.2±45.7 119.7±39.6 0.100 0.001
 Triglycerides, mg/dL 104.9±48.9 131.8±72.0 123.0±37.0 138.6±92.6 124.5±67.0 0.024 0.012
 Low-density lipoprotein, mg/dL 114.6±31.6 118.7±33.6 112.2±27.7 120.3±36.0 116.4±32.3 0.468 0.549
 HbA1c, % 5.8±0.8 6.3±1.6 6.5±1.4 6.9±1.7 6.6±1.4 0.001 0.001
 Insulin, µIU/mL 6.4±4.5 6.4±5.1 8.0±7.6 7.3±8.6 7.0±6.7 0.439 0.071
 C-reactive protein, mg/dL 0.7±1.8 0.8±2.3 0.8±1.7 0.6±1.4 0.7±1.8 0.916 0.725
Stroke classification 0.770 N/A
 Large-artery atherosclerosis 18 (27.3) 20 (30.8) 27 (40.9) 26 (39.4) 91 (34.6)
 Lacune 26 (39.4) 25 (38.5) 19 (28.8) 19 (28.8) 89 (33.8)
 Cardioembolism 14 (21.2) 11 (16.9) 11 (16.7) 9 (13.6) 45 (17.1)
 Multiple causes 2 (3.0) 5 (7.7) 4 (6.1) 6 (9.1) 17 (6.5)
 Negative evaluation 6 (9.1) 4 (6.2) 5 (7.6) 6 (9.1) 21 (8.0)
NIHSS score 3 [1–6] 2 [1–6] 3 [1–5] 3 [2–5] 3 [1–6] 0.404 0.695
Early neurological deterioration 5 (7.6) 6 (9.2) 6 (9.1) 3 (4.5) 20 (7.6) 0.722 0.529
High-grade WMHs 15 (22.7) 14 (21.5) 13 (19.7) 26 (39.4) 68 (25.9) 0.035 0.047
Symptomatic cerebral atherosclerosis 18 (27.3) 20 (30.8) 19 (28.8) 25 (37.9) 82 (31.2) 0.566 0.244
SQFFQ data
 GI 59.6 [56.1–62.4] 58.5 [54.9–62.3] 59.4 [56.4–62.4] 60.6 [57.3–63.4] 59.6 [56.2–62.7] 0.038 0.004
 Total carbohydrates, g/day 148.5 [125.0–169.4] 215.2 [197.2–232.1] 286.2 [268.8–306.3] 372.0 [328.4–450.5] 245.6 [180.7–321.1] 0.001 0.001
 Total energy, kcal 1,231.6±444.1 1,665.4±424.3 2,081.7±559.3 2,863.5±803.8 1,961.7±833.9 0.001 0.001
 Fat, g/day 38.1±24.6 47.3±22.3 56.9±30.0 76.7±35.3 54.8±31.8 0.001 0.001
 Protein, g/day 54.2±24.7 69.6±25.9 85.0±32.8 109.6±36.7 79.6±36.6 0.001 0.001
 Dietary fiber, g/day 16.2±7.2 22.9±10.5 29.4±10.2 35.7±13.9 26.0±12.9 0.001 0.001
 Grains, g/day 260.7±229.6 355.6±605.9 307.4±162.2 456.7±261.2 345.1±362.7 0.013 0.004
 Starch, g/day 42.5±59.1 72.6±159.7 45.3±54.6 63.1±81.8 55.8±98.3 0.001 0.165
 Sugar, g/day 32.7±54.1 31.0±35.6 32.7±35.6 40.3±46.8 34.2±43.7 0.625 0.070

Data are median [interquartile range], n (%), or mean±standard deviation values.

Q1 and Q4, top and bottom quartiles of the GI, respectively.

*p<0.05, †p<0.1.

GI: glycemic index, GL: glycemic load, HbA1c: hemoglobin A1c, mRS: modified Rankin Scale, NIHSS: National Institutes of Health Stroke Scale, SQFFQ: semiquantitative food-frequency questionnaire, WMHs: white-matter hyperintensities.

Table 2

Comparison of demographic and clinical data according to quartiles of total carbohydrate intake

jcn-14-165-i002
Variables Q1 (n=66) Q2 (n=65) Q3 (n=66) Q4 (n=66) Total (n=263) p* p for trend†
Total carbohydrates, g/day 147.4 [124.6–169.0] 214.6 [200.0–227.9] 285.4 [269.6–304.7] 374.9 [341.2–450.5] 245.6 [180.7–321.1]
Demographic data
 Sex, male 34 (52.3) 33 (50.0) 44 (66.7) 42 (63.6) 153 (58.2) 0.139 0.064
 Age, years 66.8±12.0 65.0±13.4 65.0±11.3 64.8±10.2 65.4±11.7 0.751 0.368
 Marital status, married 41 (63.1) 43 (65.2) 45 (68.2) 43 (65.2) 172 (65.4) 0.943 0.726
 Education, >7 years 11 (16.9) 15 (22.7) 15 (22.7) 8 (12.1) 49 (18.6) 0.330 0.498
 Prestroke mRS score 0 [0–1] 0 [0–1] 0 [0–1] 0 [0–1] 0 [0–1] 0.157 0.513
Risk factors
 Hypertension 23 (35.4) 35 (53.0) 32 (48.5) 31 (47.0) 121 (46.0) 0.217 0.278
 Diabetes mellitus 15 (23.1) 23 (34.8) 26 (39.4) 30 (45.5) 94 (35.7) 0.054 0.007
 Hyperlipidemia 9 (13.8) 21 (31.8) 15 (22.7) 9 (13.6) 54 (20.5) 0.029 0.651
 Alcohol intake 24 (36.9) 28 (42.4) 30 (45.5) 36 (54.5) 118 (44.9) 0.228 0.387
 Smoking 23 (35.4) 21 (31.8) 31 (47.0) 28 (42.4) 103 (39.2) 0.276 0.179
 Body mass index, kg/m2 27.2±3.5 24.3±3.4 24.1±3.0 23.6±3.3 24.8±2.2 0.336 0.109
 Regular exercise 21 (32.3) 24 (36.4) 22 (33.3) 28 (42.4) 95 (36.1) 0.621 0.304
Laboratory findings
 White blood cell count, ×103/µL 7.1±3.2 6.8±1.9 8.2±3.1 7.6±2.8 7.4±2.8 0.040 0.073
 Hemoglobin, mg/dL 13.4±1.5 13.2±1.5 13.3±2.1 13.3±1.3 13.3±1.6 0.932 0.942
 Fasting glucose, mg/dL 114.5±35.6 117.0±38.8 114.6±35.1 132.7±45.9 119.7±39.6 0.023 0.018
 Triglycerides, mg/dL 107.8±51.3 128.2±67.2 129.5±62.9 132.4±81.5 124.5±67.0 0.136 0.043
 Low-density lipoprotein, mg/dL 111.2±26.5 122.4±36.0 113.3±29.4 118.7±35.8 116.4±32.3 0.179 0.451
 HbA1c, % 6.0±0.8 6.4±1.6 6.4±1.4 6.9±1.7 6.6±1.4 0.007 0.001
 Insulin, µIU/mL 6.4±4.5 6.3±6.9 8.0±7.7 7.3±8.2 7.0±6.7 0.342 0.174
 C-reactive protein, mg/dL 0.7±1.8 0.7±2.3 0.5±1.2 0.9±1.9 0.7±1.8 0.839 0.849
Stroke classification 0.635 N/A
 Large-artery atherosclerosis 16 (24.6) 22 (33.3) 28 (42.4) 25 (37.9) 91 (34.6)
 Lacune 28 (43.1) 22 (33.3) 19 (28.8) 20 (30.3) 89 (33.8)
 Cardioembolism 14 (21.5) 10 (15.2) 10 (15.2) 11 (16.7) 45 (17.1)
 Multiple causes 2 (3.1) 7 (10.6) 4 (6.1) 4 (6.1) 17 (6.5)
 Negative evaluation 5 (7.7) 5 (7.6) 5 (7.6) 6 (9.1) 21 (8.0)
NIHSS score 3 [1–5] 2 [1–6] 3 [1–5] 3 [2–5] 3 [1–6] 0.301 0.151
Early neurological deterioration 5 (7.7) 6 (9.1) 5 (7.6) 4 (6.1) 20 (7.6) 0.934 0.661
High-grade WMHs 16 (24.6) 15 (22.7) 15 (22.7) 22 (33.3) 68 (25.9) 0.449 0.279
Symptomatic cerebral atherosclerosis 16 (24.6) 23 (34.8) 19 (28.8) 24 (36.4) 82 (31.2) 0.437 0.256
SQFFQ data
 GL 90.0 [77.0–98.3] 126.4 [112.8–136.1] 170.7 [163.2–183.2] 222.2 [195.7–268.8] 144.9 [106.0–188.5] 0.001 0.001
 GI 60.9 [58.1–62.9] 58.4 [54.6–62.7] 60.4 [57.4–62.8] 59.6 [55.3–62.1] 59.6 [56.2–62.7] 0.174 0.286
 Total energy, kcal 1,170.6±395.6 1,660.8±375.4 2,056.8±453.8 2,946.5±768.4 1,961.7±833.9 0.001 0.001
 Fat, g/day 34.2±21.7 47.2±20.1 55.7±26.5 81.6±35.8 54.8±31.8 0.001 0.001
 Protein, g/day 49.1±19.8 69.0±20.7 83.8±27.4 116.3±37.4 79.6±36.6 0.001 0.001
 Dietary fiber, g/day 28.4±9.3 39.2±13.2 26.0±12.9 0.001 0.001
 Grains, g/day 253.2±224.9 364.2±601.8 301.2±128.1 460.2±278.5 345.1±362.7 0.007 0.005
 Starch, g/day 35.9±37.3 75.0±164.3 40.4±42.1 71.7±86.7 55.8±98.3 0.035 0.183
 Sugar, g/day 32.9±54.4 29.0±34.4 33.4±33.6 41.4±48.7 34.2±43.7 0.422 0.213

Data are median [interquartile range], n (%), or mean±standard-deviation values.

*p<0.05, †p<0.1.

GI: glycemic index, GL: glycemic load, HbA1c: hemoglobin A1c, mRS: modified Rankin Scale, NIHSS: National Institutes of Health Stroke Scale, SQFFQ: semiquantitative food-frequency questionnaire, WMHs: white-matter hyperintensities.

Table 3

Associations of dietary GL, GI, and total carbohydrate intake with a poor functional outcome

jcn-14-165-i003
Variables GL GI Total carbohydrates
Binary logistic regression (mRS score=0–2 versus 3–6)
 Continuous variables, OR (95% CI), p 1.01 (1.00–1.02), 0.003 1.00 (0.89–1.12), 0.982 1.01 (1.00–1.02), 0.005
 Ordinal variables, quartile; OR (95% CI), p for trend 3.38 (1.66–6.90), 0.002 1.20 (0.71–2.03), 0.481 3.08 (1.50–6.32), 0.002
  Q1, Reference 1 1 1
  Q2, OR (95% CI), p 6.31 (0.59–67.39), 0.127 4.25 (0.69–25.94), 0.117 12.64 (1.12–142.14), 0.040
  Q3, OR (95% CI), p 32.78 (2.81–381.86), 0.005 1.83 (0.26–12.63), 0.538 20.64 (1.68–253.56), 0.018
  Q4, OR (95% CI), p 28.93 (2.82–296.04), 0.005 3.60 (0.54–23.76), 0.182 36.84 (2.99–453.42), 0.005
Ordinal logistic regression (mRS score=0, 1, 2, 3–6)
 Continuous variables, OR (95% CI), p 1.00 (1.00–1.03), 0.005 1.03 (0.95–1.11), 0.519 1.00 (1.00–1.03), 0.006
 Ordinal variables, quartile; OR (95% CI), p for trend 1.58 (1.10–2.27), 0.014 1.20 (0.86–1.69), 0.284 1.69 (1.16–2.45), 0.006
  Q1, Reference 1 1 1
  Q2, OR (95% CI), p 1.06 (0.51–6.63), 0.356 1.99 (0.67–5.91), 0.215 2.67 (0.73–9.72), 0.137
  Q3, OR (95% CI), p 6.82 (1.99–23.57), 0.002 1.77 (0.57–5.46), 0.321 7.66 (2.08–28.22), 0.002
  Q4, OR (95% CI), p 4.71 (1.32–16.78), 0.017 2.02 (0.66–6.20), 0.217 5.00 (1.35–18.62), 0.016

Adjusted for age, sex, variables with p<0.1 in univariate analysis (marital status, prestroke mRS score, hyperlipidemia, body mass index, stroke classification, National Institutes of Health Stroke Scale score, early neurological deterioration, and high-grade white-matter hyperintensities), and variables related to GL, GI, or total carbohydrate intake (diabetes mellitus, triglycerides, low-density lipoprotein, and hemoglobin A1c).

CI: confidence interval, GI: glycemic index, GL: glycemic load, mRS: modified Rankin Scale, OR: odds ratio.

Table 4

Associations of dietary GL, GI, and total carbohydrate intake with a poor functional outcome according to presence of diabetes mellitus

jcn-14-165-i004
Variables Continuous variables Ordinal variables (quartiles)
OR (95% CI) p* OR (95% CI) p for trend*
Without diabetes mellitus
 GL 1.02 (1.01–1.07) 0.010 2.57 (1.10–6.01) 0.029
 GI 0.92 (0.78–1.08) 0.336 0.75 (0.39–1.45) 0.403
 Total carbohydrates 1.01 (1.01–1.02) 0.041 2.25 (1.03–4.91) 0.041
With diabetes mellitus
 GL 1.04 (1.01–1.09) 0.048 10.96 (1.06–112.52) 0.044
 GI 1.27 (0.93–1.73) 0.121 4.71 (0.95–23.34) 0.058
 Total carbohydrates 1.02 (1.01–1.04) 0.028 4.93 (1.02–23.82) 0.047

*Adjusted for age, sex, variables with p<0.1 in univariate analysis (marital status, prestroke modified Rankin Scale score, hyperlipidemia, body mass index, stroke classification, National Institutes of Health Stroke Scale score, early neurological deterioration, and high-grade white-matter hyperintensities), and variables related to GL, GI, or total carbohydrate intake (diabetes mellitus, triglycerides, low-density lipoprotein, and hemoglobin A1c).

CI: confidence interval, GI: glycemic index, GL: glycemic load, OR: odds ratio.

TOOLS
Similar articles